Yana Pikman

4.6k total citations · 2 hit papers
41 papers, 2.7k citations indexed

About

Yana Pikman is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Yana Pikman has authored 41 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 20 papers in Molecular Biology and 14 papers in Genetics. Recurrent topics in Yana Pikman's work include Acute Myeloid Leukemia Research (19 papers), Acute Lymphoblastic Leukemia research (13 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Yana Pikman is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Acute Lymphoblastic Leukemia research (13 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Yana Pikman collaborates with scholars based in United States, France and Germany. Yana Pikman's co-authors include Ross L. Levine, Martha Wadleigh, D. Gary Gilliland, Gerlinde Wernig, Ilene Galinsky, Daniel J. DeAngelo, Benjamin H. Lee, Sandra Moore, Thomas Mercher and Maricel Gozo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Yana Pikman

41 papers receiving 2.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

2006 1.0k citations Yana Pikman, Benjamin H. Lee et al. PLoS Medicine profile →
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

2006 758 citations Ross L. Levine, Yana Pikman et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yana Pikman United States	15	2.0k	1.8k	1.5k	711	279	41	2.7k
Agnès Guerci France	19	1.3k 0.7×	1.9k 1.0×	463 0.3×	666 0.9×	247 0.9×	49	2.1k
David M. Ross Australia	28	2.1k 1.0×	2.6k 1.4×	408 0.3×	1.2k 1.7×	482 1.7×	143	3.0k
Guillermo Garcia‐Manero United States	24	834 0.4×	1.3k 0.7×	532 0.3×	271 0.4×	248 0.9×	40	1.8k
Rajko Kušec Croatia	24	887 0.4×	1.0k 0.6×	979 0.6×	225 0.3×	280 1.0×	104	2.0k
Erica Travaglino Italy	20	1.3k 0.6×	2.0k 1.1×	488 0.3×	108 0.2×	253 0.9×	57	2.3k
Angelo Guerrasio Italy	24	547 0.3×	938 0.5×	787 0.5×	145 0.2×	255 0.9×	105	1.7k
H. Pralle Germany	21	869 0.4×	1.3k 0.7×	275 0.2×	410 0.6×	284 1.0×	65	1.8k
Ingunn Dybedal Norway	19	781 0.4×	1.5k 0.8×	429 0.3×	136 0.2×	222 0.8×	39	1.9k
Friedrich Wimazal Austria	24	626 0.3×	1.1k 0.6×	344 0.2×	351 0.5×	189 0.7×	52	2.0k
Jean-Paul Fermand France	11	674 0.3×	735 0.4×	1.2k 0.8×	123 0.2×	209 0.7×	13	1.6k

Countries citing papers authored by Yana Pikman

Since Specialization

Citations

This map shows the geographic impact of Yana Pikman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yana Pikman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yana Pikman more than expected).

Fields of papers citing papers by Yana Pikman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yana Pikman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yana Pikman. The network helps show where Yana Pikman may publish in the future.

Co-authorship network of co-authors of Yana Pikman

This figure shows the co-authorship network connecting the top 25 collaborators of Yana Pikman. A scholar is included among the top collaborators of Yana Pikman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yana Pikman. Yana Pikman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Popescu, Bogdan, Matthew F. Jones, Cheryl A.C. Peretz, et al.. (2025). Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML. Blood. 147(3). 276–289. 1 indexed citations

Tsai, Harrison, et al.. (2024). IKZF1 Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia. Biomedicines. 12(1). 89–89. 12 indexed citations

Wheeler, Emily C., Benjamín Martín, Melanie Donahue, et al.. (2024). Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML. Science Translational Medicine. 16(728). eade2774–eade2774. 17 indexed citations

Chen, Chun-Chin, Duanduan Ma, Jennifer A. Perry, et al.. (2024). Inherent genome instability underlies trisomy 21-associated myeloid malignancies. Leukemia. 38(3). 521–529. 8 indexed citations

Wachter, Franziska, Kyle Hebert, Yana Pikman, et al.. (2023). Impact of cytoreduction and remission status on hematopoietic cell transplantation outcomes in pediatric myelodysplastic syndrome and related disorders. Pediatric Blood & Cancer. 70(9). e30530–e30530. 4 indexed citations

Wachter, Franziska, Yana Pikman, Jacob R. Bledsoe, et al.. (2023). Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation. SHILAP Revista de lepidopterología. 11(11). e8190–e8190. 1 indexed citations

Wachter, Franziska, Roberto Chiarle, Neal I. Lindeman, et al.. (2022). Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn. Blood Advances. 6(9). 2893–2896. 1 indexed citations

Pikman, Yana, Gabriela Alexe, Boris Dimitrov, et al.. (2021). Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy. Leukemia. 36(2). 348–360. 36 indexed citations

Pikman, Yana, Amy Saur Conway, Amanda L. Robichaud, et al.. (2020). Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma. Blood Advances. 4(7). 1265–1269. 5 indexed citations

10.

Cremer, Anjali, Jana M. Ellegast, Gabriela Alexe, et al.. (2019). Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia. Cancer Discovery. 10(2). 214–231. 26 indexed citations

11.

Place, Andrew E., Yana Pikman, Kristen E. Stevenson, et al.. (2018). Phase I trial of the mTOR inhibitor everolimus in combination with multi‐agent chemotherapy in relapsed childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. 65(7). e27062–e27062. 43 indexed citations

12.

Pikman, Yana, Sarah K. Tasian, Maria Luisa Sulis, et al.. (2018). Matched targeted therapy for pediatric patients with relapsed, refractory or high-risk leukemias: A report from the LEAP consortium.. Journal of Clinical Oncology. 36(15_suppl). 10518–10518. 5 indexed citations

13.

Pikman, Yana & Kimberly Stegmaier. (2018). Targeted therapy for fusion-driven high-risk acute leukemia. Blood. 132(12). 1241–1247. 18 indexed citations

14.

Pikman, Yana, Gabriela Alexe, Giovanni Roti, et al.. (2016). Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia. Clinical Cancer Research. 23(4). 1012–1024. 81 indexed citations

15.

Green, Adam L., Yana Pikman, Venée N. Tubman, et al.. (2015). A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients. Pediatric Blood & Cancer. 63(1). 112–117. 7 indexed citations

16.

Place, Andrew E., Yana Pikman, Kristen E. Stevenson, et al.. (2015). Phase Ib Trial of the mTOR Inhibitor Everolimus Given in Combination with Multiagent Chemotherapy in Relapsed Acute Lymphoblastic Leukemia. Blood. 126(23). 3765–3765. 3 indexed citations

17.

Puissant, Alexandre, Nina Fenouille, Gabriela Alexe, et al.. (2014). SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia. Cancer Cell. 25(2). 226–242. 109 indexed citations

18.

Pikman, Yana & Ross L. Levine. (2007). Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders. Current Opinion in Oncology. 19(6). 628–634. 6 indexed citations

19.

Neilan, Edward, Yana Pikman, & Virginia Kimonis. (2006). Peters Anomaly in Association with Multiple Midline Anomalies and a Familial Chromosome 4 Inversion. Ophthalmic Genetics. 27(2). 63–65. 12 indexed citations

20.

Pikman, Yana, Benjamin H. Lee, Thomas Mercher, et al.. (2006). MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia. PLoS Medicine. 3(7). e270–e270. 1024 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact